|Solubility:||DMSO ≥30 mg/mL|
|Long-term Storage:||at -20°C|
|HPLC:||Shows Min 99.04% purity|
|H-NMR:||Consistent with structure|
|Description:||Ponatinib (AP24534) is a novel potent, orally available small molecule multitargeted kinase inhibitor of BCR-ABL, PDGFRα, c-Src, c-Kit, FGFR and VEGFR.|
|Stability and Solubility Advice:|| Information concerning product stability, particularly in solution, has rarely been reported and in most cases we can only offer a general guide.
We recommend that stock solutions, once prepared, are stored aliquoted in tightly sealed vials at -20°C or below and used within 1 month.